|
丸子 一朗
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position Associate Professor |
|
| Article types | Case report |
| Language | English |
| Peer review | Peer reviewed |
| Title | Acute idiopathic maculopathy after COVID-19 vaccination. |
| Journal | Formal name：American journal of ophthalmology case reports Abbreviation：Am J Ophthalmol Case Rep ISSN code：24519936/24519936 |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 26,pp.101479 |
| Author and coauthor | Hasegawa Taiji |
| Publication date | 2022/03 |
| Summary | Purpose:We report a case of acute idiopathic maculopathy (AIM) that developed after COVID-19 vaccination.Observations:A 54-year-old woman complained of a sudden decrease of visual acuity in her right eye one day after receiving a second COVID-19 vaccination (Pfizer). Fundus photograph showed a circular yellow lesion at the fovea in right eye. Optical coherence tomography revealed the thickening of retinal pigment epithelium and the presence of subretinal fluid. Three months after the initial visit, the BCVA and the fundus images had favorable recovery in the right eye.Conclusions and Importance:We describe a case of AIM after receiving COVID-19 vaccination. These findings may be a helpful in understanding the pathogenesis of AIM. |
| DOI | 10.1016/j.ajoc.2022.101479 |
| PMID | 35282606 |